NCT02785939 2021-05-27Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung CancerSWOG Cancer Research NetworkPhase 2/3 Completed53 enrolled 15 charts